Volume 2, Issue 10
Acknowledgementsp. 1047
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 10
Editorialp. 953–955
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Author(s): Marc S Ernstoff
Editorialp. 957–959
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Author(s): Walter J Urba, Brendan D Curti
News and Viewsp. 961–964
Clinical trial identifies potential new treatments for infantile eczema
Interviewp. 967–970
Update from recent blepharitis clinical trials: interview with James McCulley
Author(s): James McCulley
Research Updatep. 971–974
Do clinical research networks work? The NIHR diabetes research network after six years
Author(s): Eleanor Kennedy, David R Matthews
Research Updatep. 975–984
Developing an international network for Alzheimers research: the Dominantly Inherited Alzheimer Network
Author(s): John C Morris, Paul S Aisen,Randall J Bateman, Tammie LS Benzinger, Nigel J Cairns,Anne M Fagan, Bernardino Ghetti, Alison M Goate,David M Holtzman, William E Klunk, Eric McDade, Daniel S Marcus,Ralph N Martins6 Colin L Masters, Richard Mayeux,Angela Oliver1 Kimberly Quaid, John M Ringman, Martin N Rossor, Stephen Salloway, Peter R Schofield, Natalie J Selsor,Reisa A Sperling11Michael W Weiner,Chengjie Xiong, Krista L Moulder, Virginia D Buckles
Review: Clinical Trail Outcomesp. 985–993
Anti-cancer potential of tumor-vascular disrupting agents: review of the latest clinical evidence
Author(s): Bruce C Baguley
Review: Clinical Trail Outcomesp. 995–1002
Abiraterone acetate for metastatic castration-resistant prostate cancer post-docetaxel
Author(s): Hein Van Poppel, Susanne Osanto,Steven Joniau
Review: Clinical Trail Outcomesp. 1003–101
Elucidating the role of androgen receptor in breast cancer
Author(s): Elgene Lim, Min Ni, Aditi Hazra, Rulla Tamimi, Myles Brown
Review: Clinical Trail Outcomesp. 1013–102
Personalized medicine in colorectal cancer: the evidence so far
Author(s): Avinash Gupta, Wasir Saka, David J Kerr
Review: Clinical Trail Outcomesp. 1023–103
Ruxolitinib for myelofibrosis
Author(s): Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomesp. 1033–103
The Role of Mipomersen Therapy in the Treatment of Familial Hypercholesterolemia
Author(s): Roda Plakogiannis, Lisa Cioce, Edward A Fisher, James A Underberg
Review: Clinical Trail Outcomesp. 1039–104
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
Author(s): JR Malagelada
